ATE227723T1 - Eintopfverfahren zur herstellung von 2- oxazolidinonderivate - Google Patents

Eintopfverfahren zur herstellung von 2- oxazolidinonderivate

Info

Publication number
ATE227723T1
ATE227723T1 AT96926465T AT96926465T ATE227723T1 AT E227723 T1 ATE227723 T1 AT E227723T1 AT 96926465 T AT96926465 T AT 96926465T AT 96926465 T AT96926465 T AT 96926465T AT E227723 T1 ATE227723 T1 AT E227723T1
Authority
AT
Austria
Prior art keywords
producing
pot process
oxazolidinone derivatives
oxazolidinone
derivatives
Prior art date
Application number
AT96926465T
Other languages
English (en)
Inventor
Rajnikant Patel
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of ATE227723T1 publication Critical patent/ATE227723T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18Oxygen atoms
    • C07D263/20Oxygen atoms attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/20Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AT96926465T 1995-08-07 1996-08-02 Eintopfverfahren zur herstellung von 2- oxazolidinonderivate ATE227723T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9516145.1A GB9516145D0 (en) 1995-08-07 1995-08-07 Improved chemical synthesis
PCT/GB1996/001885 WO1997006162A1 (en) 1995-08-07 1996-08-02 One pot synthesis of 2-oxazolidinone derivatives

Publications (1)

Publication Number Publication Date
ATE227723T1 true ATE227723T1 (de) 2002-11-15

Family

ID=10778867

Family Applications (2)

Application Number Title Priority Date Filing Date
AT02008427T ATE325121T1 (de) 1995-08-07 1996-08-02 Verfahren zur reinigung von (s)-4- ((dimethylamino)ethyl)-1h-indol-5yl)-methyl)-2- oxazolidinone
AT96926465T ATE227723T1 (de) 1995-08-07 1996-08-02 Eintopfverfahren zur herstellung von 2- oxazolidinonderivate

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT02008427T ATE325121T1 (de) 1995-08-07 1996-08-02 Verfahren zur reinigung von (s)-4- ((dimethylamino)ethyl)-1h-indol-5yl)-methyl)-2- oxazolidinone

Country Status (34)

Country Link
US (2) US6084103A (de)
EP (2) EP1227095B1 (de)
JP (6) JP3729503B2 (de)
KR (1) KR100670704B1 (de)
CN (3) CN1092657C (de)
AR (2) AR006515A1 (de)
AT (2) ATE325121T1 (de)
AU (1) AU718413B2 (de)
BR (1) BR9609830A (de)
CA (2) CA2572508C (de)
CZ (2) CZ301603B6 (de)
DE (2) DE69624825T2 (de)
DK (2) DK0843672T3 (de)
ES (2) ES2261545T3 (de)
GB (1) GB9516145D0 (de)
HK (2) HK1009129A1 (de)
HU (1) HU229966B1 (de)
IL (4) IL123171A (de)
IN (2) IN185148B (de)
MX (1) MX9801044A (de)
MY (1) MY117571A (de)
NO (2) NO311690B1 (de)
NZ (1) NZ315040A (de)
PL (1) PL188805B1 (de)
PT (2) PT1227095E (de)
RO (2) RO119618B1 (de)
RU (1) RU2167875C2 (de)
SI (2) SI1227095T1 (de)
SK (1) SK285052B6 (de)
TR (1) TR199800182T1 (de)
TW (1) TW358811B (de)
UA (1) UA53625C2 (de)
WO (1) WO1997006162A1 (de)
ZA (1) ZA966711B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001004088A1 (fr) * 1999-07-09 2001-01-18 Chugai Seiyaku Kabushiki Kaisha Procede de preparation de derives d'amiline
ES2204302B2 (es) * 2002-08-07 2005-03-01 Laboratorios Vita, S.A. Procedimiento para la obtencion de un compuesto farmaceuticamente activo.
US20070173536A1 (en) * 2004-02-06 2007-07-26 Ciba Specialty Chemicals Holding Inc. Crystalline forms of zolmitriptan
US20060211751A1 (en) * 2004-11-19 2006-09-21 Reuven Izsak Zolmitriptan crystal forms
JP4935675B2 (ja) 2005-08-25 2012-05-23 宇部興産株式会社 光学活性(S又はR)−α−アミノ酸及び光学活性(R又はS)−α−アミノ酸エステルの製造方法
ATE510836T1 (de) 2006-01-19 2011-06-15 Matrix Lab Ltd Umwandlung eines aromatischen diazoniumsalzes in ein arylhydrazin
WO2008007390A2 (en) * 2006-07-10 2008-01-17 Natco Pharma Limited An improved process for purification of zolmitriptan
WO2008018090A2 (en) * 2006-08-09 2008-02-14 Matrix Laboratories Ltd An improved process for the preparation of zolmitriptan
CZ2007158A3 (cs) * 2007-02-26 2008-10-22 Zentiva, A. S. Zpusob prípravy zolmitriptanu
CZ301538B6 (cs) * 2007-02-26 2010-04-07 Zentiva, A. S. Zpusob prípravy zolmitriptanu
EP2201003A1 (de) 2007-10-03 2010-06-30 Generics Ýuk¨Limited Verfahren zur herstellung von zolmitriptan, salzen und solvaten davon
CN101230047B (zh) * 2008-02-04 2010-08-04 江苏中威药业有限公司 一种4-取代手性噁唑烷酮类化合物的制备方法
EP2387993B1 (de) * 2010-05-21 2012-11-07 Sanovel Ilaç Sanayi Ve Ticaret Anonim Sirketi Im Mund zerfallende Zolmitriptan-Tabletten und Herstellungsverfahren dafür
CN101948443B (zh) * 2010-08-17 2012-08-22 河南师范大学 一种简单、高效合成4-取代噁唑烷酮衍生物的方法
WO2012135615A2 (en) 2011-03-30 2012-10-04 Brown University Enopeptins, uses thereof, and methods of synthesis thereto
EP2751098B1 (de) 2011-09-02 2017-11-29 Emcure Pharmaceuticals Limited Verbessertes verfahren zur herstellung von zolmitriptan
CN102964270B (zh) * 2012-11-21 2015-01-07 合肥星宇化学有限责任公司 一种亚硫酸钠还原重氮盐合成肼的方法
CN103275075B (zh) * 2013-06-24 2015-01-07 成都天台山制药有限公司 佐米曲普坦及其制备方法
WO2016037072A2 (en) * 2014-09-04 2016-03-10 Brown University Enopeptin analogas and methods of use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8724912D0 (en) * 1987-10-23 1987-11-25 Wellcome Found Indole derivatives
IL98392A (en) * 1990-06-07 1996-01-19 Wellcome Found History of indole, their preparation and the pharmaceutical preparations containing them
GB9401436D0 (en) * 1994-01-26 1994-03-23 Wellcome Found Therapeutic heterocyclic compounds
GB9423682D0 (en) * 1994-11-23 1995-01-11 Merck Sharp & Dohme Therapeutic agents
WO1996017842A1 (en) * 1994-12-06 1996-06-13 Merck Sharp & Dohme Limited Azetidine, pyrrolidine and piperidine derivatives as 5ht1 receptor agonists

Also Published As

Publication number Publication date
CA2572508C (en) 2010-03-30
KR100670704B1 (ko) 2007-07-11
CZ35298A3 (cs) 1998-06-17
CA2572508A1 (en) 1997-02-20
SK15498A3 (en) 1998-06-03
IN189756B (de) 2003-04-19
CZ301603B6 (cs) 2010-04-28
JP4634286B2 (ja) 2011-02-16
MY117571A (en) 2004-07-31
IL148030A (en) 2010-05-17
EP1227095A3 (de) 2003-11-19
CA2227039A1 (en) 1997-02-20
MX9801044A (es) 1998-05-31
CA2227039C (en) 2007-12-04
EP1227095A2 (de) 2002-07-31
EP0843672B1 (de) 2002-11-13
HUP9900188A2 (hu) 1999-05-28
JP2006225406A (ja) 2006-08-31
HUP9900188A3 (en) 1999-11-29
SK285052B6 (sk) 2006-05-04
KR19990036165A (ko) 1999-05-25
CN1317480A (zh) 2001-10-17
JP2006077025A (ja) 2006-03-23
DK1227095T3 (da) 2006-07-31
ZA966711B (en) 1997-02-18
NO311690B1 (no) 2002-01-07
TR199800182T1 (xx) 1998-05-21
CN1142904C (zh) 2004-03-24
EP1227095B1 (de) 2006-05-03
US6160123A (en) 2000-12-12
CN1092657C (zh) 2002-10-16
NZ315040A (en) 2000-01-28
AR006515A1 (es) 1999-09-08
DE69636107T2 (de) 2007-05-03
AU6663496A (en) 1997-03-05
DE69624825T2 (de) 2003-09-04
NO20005187D0 (no) 2000-10-16
ES2185790T3 (es) 2003-05-01
TW358811B (en) 1999-05-21
JP2002097178A (ja) 2002-04-02
CZ293050B6 (cs) 2004-01-14
JP3739678B2 (ja) 2006-01-25
CN1403455A (zh) 2003-03-19
BR9609830A (pt) 1999-03-09
ATE325121T1 (de) 2006-06-15
ES2261545T3 (es) 2006-11-16
RO119618B1 (ro) 2005-01-28
PT843672E (pt) 2003-03-31
AU718413B2 (en) 2000-04-13
SI0843672T1 (en) 2003-04-30
PL324881A1 (en) 1998-06-22
IL123171A (en) 2003-10-31
JP3729503B2 (ja) 2005-12-21
GB9516145D0 (en) 1995-10-04
RU2167875C2 (ru) 2001-05-27
JPH11513023A (ja) 1999-11-09
UA53625C2 (uk) 2003-02-17
IL123171A0 (en) 1998-09-24
HU229966B1 (hu) 2015-03-30
NO980522D0 (no) 1998-02-06
SI1227095T1 (sl) 2006-08-31
CN1244579C (zh) 2006-03-08
IL156733A (en) 2007-07-04
WO1997006162A1 (en) 1997-02-20
JP2002308858A (ja) 2002-10-23
HK1047094A1 (en) 2003-02-07
DE69636107D1 (de) 2006-06-08
DE69624825D1 (de) 2002-12-19
CN1201460A (zh) 1998-12-09
HK1047094B (zh) 2006-10-13
PT1227095E (pt) 2006-08-31
IN185148B (de) 2000-11-25
PL188805B1 (pl) 2005-04-29
HK1009129A1 (en) 1999-05-28
IL148030A0 (en) 2002-09-12
JP2002037786A (ja) 2002-02-06
NO311691B1 (no) 2002-01-07
NO980522L (no) 1998-02-06
US6084103A (en) 2000-07-04
RO121816B1 (ro) 2008-05-30
NO20005187L (no) 1998-02-06
IL156733A0 (en) 2004-02-08
EP0843672A1 (de) 1998-05-27
DK0843672T3 (da) 2003-02-17
AR046236A2 (es) 2005-11-30

Similar Documents

Publication Publication Date Title
DE69628712D1 (de) Verfahren zur Herstellung von Dihalogenazolopyrimidinen
ATE227723T1 (de) Eintopfverfahren zur herstellung von 2- oxazolidinonderivate
ATE309266T1 (de) Prozess zur herstellung bestimmter aza- zyklohexapeptide
DE59607656D1 (de) Verfahren zur Herstellung von Alkylhydrogenchlorsilanen
DE69502384D1 (de) Prozess zur herstellung von polyarylenetherketonen
DE69510596T2 (de) Verfahren zur Herstellung von Organooxysilane
DE59608829D1 (de) Verfahren zur Herstellung von 1,3-Dimethyl-5-fluor-pyrazol-4-carboxaniliden
DE69619067D1 (de) Verfahren zur Herstellung von 3-Amino-2-oxo-1-Halogenpropan-Derivaten
DE59603916D1 (de) Verfahren zur Herstellung von Imidazo-Benzodiazepin-Derivaten
DE69625253T2 (de) Verfahren zur Herstellung von Imidazochinazolinon-Derivaten
DE69635421T2 (de) Verfahren zur herstellung von 2-chlorthiazolderivaten
DE69700509T2 (de) Verfahren zur Herstellung von Allylsilanen
DE69604875D1 (de) Verfahren zur Herstellung von Cyclopentadienylderivaten
DE59607308D1 (de) Verfahren zur Herstellung von SiH-haltigen Organylchlorsilanen
DE69611331D1 (de) Verfahren zur Herstellung von S-Phenyl-L-Cystein
DE69600385D1 (de) Verfahren zur Herstellung von Aminonitropyridinen
DE69627117D1 (de) Verfahren zur Herstellung von Zellulose
DE69603243D1 (de) Verfahren zur Herstellung von Ethenylamiden
DE59605105D1 (de) Verfahren zur Herstellung von substituierten Aminocarbonyltriazolinonen
DE69607541D1 (de) Verfahren zur Herstellung von p-Bromfluorobenzol
DE69513008T2 (de) Verfahren zur Herstellung von Hydroxyalkoxybenzophenonen
DE59611076D1 (de) Verfahren zur herstellung von 5,6-dihydro-1,3-oxazinen
ATE203750T1 (de) Eintopfverfahren zur herstellung von pergolid
DE59605227D1 (de) Verfahren zur Herstellung von ortho-Nitro-benzonitrilen
DE59601809D1 (de) Verfahren zur Herstellung von substituierten Aminotriazolinonen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0843672

Country of ref document: EP